Travere Therapeutics names new CEO effective December 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. USO
2. NVDA
3. META
4. SPY
5. DCOY
6. MSFT
7. VKTX
8. PRGS
9. IONQ
10. VRTX

Go back to Travere Therapeutics names new CEO effective December 2026
(NASDAQ: TVTX) Delayed: 60.28 -2.58 (4.1%)
Previous Close $62.86    52 Week High $ 
Open $60.37    52 Week Low $ 
Day High $62.45    P/E N/A 
Day Low $59.30    EPS $ 
Volume 3,120,192